Extracellular-Regulated Protein Kinase 5-Mediated Control of p21 Expression Promotes Macrophage Proliferation Associated with Tumor Growth and Metastasis
- 14 August 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (16), 3319-3330
- https://doi.org/10.1158/0008-5472.can-19-2416
Abstract
The presence of immunosuppressive macrophages that become activated in the tumor microenvironment constitutes a major factor responsible for tumor growth and malignancy. In line with this knowledge, we report here that macrophage proliferation is a significant feature of advanced stages of cancer. Moreover, we have found that a high proportion of proliferating macrophages in human tumors express ERK5. ERK5 was required for supporting the proliferation of macrophages in tumor grafts in mice. Furthermore, myeloid ERK5 deficiency negatively impacted the proliferation of both resident and infiltrated macrophages in metastatic lung nodules. ERK5 maintained the capacity of macrophages to proliferate by suppressing p21 expression to halt their differentiation program. Collectively, these data provide insight into the mechanism underpinning macrophage proliferation to support malignant tumor development, thereby strengthening the value of ERK5-targeted therapies to restore antitumor immunity through the blockade of protumorigenic macrophage activation. Significance: These findings offer a new rationale for anti-ERK5 therapy to improve cancer patient outcomes by blocking the proliferative activity of tumor macrophages.Keywords
Other Versions
Funding Information
- Worldwide Cancer Research
- Medical Research Council Confidence in Concept
- Marie Curie Research
- Fondazione Beretta
- Associazione Italiana per la Ricerca sul Cancro (15378)
This publication has 49 references indexed in Scilit:
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcomeBreast Cancer Research and Treatment, 2010
- Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia ProteinCancer Cell, 2010
- Erk5 Activation Elicits a Vasoprotective Endothelial Phenotype via Induction of Krüppel-like Factor 4 (KLF4)Journal of Biological Chemistry, 2010
- Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) MonocytesCancer Research, 2010
- Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 ReceptorCancer Research, 2009
- A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and GrowthPLOS ONE, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Functional Interaction of STAT3 Transcription Factor with the Cell Cycle Inhibitor p21Journal of Biological Chemistry, 2000